Join Dr Hugh Calkins for a discussion of his groundbreaking paper: Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.

Catheter ablation is an antiarrhythmic surgical technique used in the treatment of atrial fibrillation. Typically, it is performed with uninterrupted anticoagulation with warfarin, or interruption of a NOAC course for a period before and following surgery. However, the results of this new study indicate that an uninterrupted course of NOACs may, in fact, be safer than other anticoagulant courses.

Latest update Time required CME credits Expiration date
14/07/2017 30 minutes Not available for CME credit N/A
  • Target audience

    This educational activity is designed for cardiologists, surgeons, primary care physicians, GPs, nurses and any other healthcare professional with an interest or role in atrial fibrillation management.

  • Learning objectives

    Upon completion of this activity, participants should be able to:

    • Identify factors that influence the choice and dose of oral anticoagulant in atrial fibrillation patients scheduled to receive an ablation procedure.
  • Staff and reviewer disclosures

    ACHL staff, PCM Scientific staff, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

  • CME accreditation

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and PCM Scientific. ACHL is accredited by the ACCME to provide continuing medical education for physicians.

    You are currently accessing the open non-accredited version of this module. If you wish to receive CME certification for this activity, please log-in or register to access the CME-accredited module.

  • Financial support

    This independent educational activity is supported by funding from Boehringer Ingelheim. PCM Scientific is the medical education company acting as scientific secretariat and organiser for this programme.

    The activity is run at arm’s length from the financial supporter and all content is created by the faculty. No funder has had input into the content of the materials or presentations available on this website.